MBCGA Launches New Advocate Research Committee

Strengthening the Voice of Patients in the Future of Male Breast Cancer Research

The Male Breast Cancer Global Alliance (MBCGA) has announced the formation of its new Advocate Research Committee, a landmark initiative designed to elevate the role of patient advocates in shaping the future of male breast cancer research, education, clinical trials, and scientific collaboration.

At a time when awareness of male breast cancer continues to expand globally, the need for informed patient representation within the research community has never been more urgent. While scientific advancements continue to improve diagnostics and treatment strategies, men diagnosed with breast cancer remain significantly underrepresented in clinical trials, educational materials, survivorship studies, and public health conversations. The new MBCGA Advocate Research Committee seeks to help bridge this gap by ensuring that the lived experiences of male breast cancer patients are integrated into research priorities and healthcare innovation.

Leading this important initiative are respected advocates and survivor-leaders Bob Riter, Rod Ritchie, and Michael Singer, each bringing years of advocacy experience, educational leadership, and a shared commitment to advancing evidence-based progress in male breast cancer care.

The committee was developed with a clear mission: to serve as a collaborative bridge between researchers, clinicians, pharmaceutical representatives, advocacy organizations, and the male breast cancer community itself. According to the committee overview, the Advocate Research Committee will focus on matters relating specifically to male breast cancer research and will assist in evaluating and supporting research initiatives through funding recommendations, scientific partnerships, advocacy guidance, and educational outreach.

Among its responsibilities, the committee will:

• Recommend research proposals that the MBCGA may support through funding, promotion, or strategic partnership.
• Meet with researchers seeking patient advocacy insight and collaboration.
• Participate in discussions with pharmaceutical trial representatives to ensure male patient perspectives are included in clinical trial design.
• Assist in organizing virtual educational meetings focused on emerging male breast cancer research.
• Review educational materials to ensure they remain aligned with current evidence and best practices.
• Mentor and encourage new advocates interested in research advocacy and scientific education.

The creation of this committee represents far more than administrative growth for the MBCGA. It reflects a growing movement within cancer care — one where survivors and advocates are no longer viewed solely as recipients of care, but as active contributors to scientific advancement and healthcare policy.

One of the most powerful aspects of the committee is its emphasis on education and mentorship. The MBCGA recognizes that effective advocacy in research requires informed participation. Committee members are encouraged to participate in nationally recognized advocacy training programs such as the National Breast Cancer Coalition’s Project LEAD, Komen’s Advocates in Science Program, the Alamo Breast Cancer Foundation Patient Advocate Program, and the American Association for Cancer Research’s Scientist-Survivor Program.

This educational framework helps equip advocates with the scientific literacy necessary to engage meaningfully with researchers, understand trial protocols, evaluate data, and contribute informed patient-centered perspectives. By fostering this level of training, the MBCGA is helping cultivate a new generation of male breast cancer research advocates who can confidently participate in national and international scientific conversations.

Committee leaders Bob Riter, Rod Ritchie, and Michael Singer each embody this mission of informed advocacy.

Bob Riter has long been recognized for his leadership in cancer advocacy and survivorship education. His work has consistently emphasized the importance of patient empowerment, evidence-based communication, and collaborative outreach between survivors and the medical community. His experience brings a thoughtful and compassionate perspective to the committee’s efforts.

Rod Ritchie contributes a strong voice for awareness, patient representation, and community engagement. Through years of involvement in advocacy initiatives, he has helped shine a light on the unique emotional and medical challenges faced by men diagnosed with breast cancer — a disease that many still incorrectly perceive as affecting only women.

Michael Singer brings additional strength to the committee through his dedication to patient education and support initiatives. His advocacy work underscores the value of research accessibility and the need to translate complex scientific information into practical, understandable resources for patients and families.

Together, the three leaders represent the heart of what the new committee hopes to accomplish: informed advocacy grounded in compassion, science, collaboration, and hope.

Importantly, the committee is not only focused on reviewing existing research but also on helping drive future innovation. Current male breast cancer clinical trials highlighted by the committee include the ETHAN Trial — a Phase II study comparing endocrine therapies for male breast cancer — as well as research exploring treatment patterns and outcomes in men with breast cancer at Vanderbilt University.

The committee also recognizes the importance of making scientific literature more visible and accessible to the public. Their foundational resource materials include notable open-access publications covering epidemiology, treatment advances, imaging, genomics, survival outcomes, screening protocols, and quality-of-life research in male breast cancer.

These publications reveal an important reality: male breast cancer research is evolving rapidly, but substantial gaps still exist in awareness, trial inclusion, long-term survivorship data, and personalized treatment strategies. The Advocate Research Committee aims to help accelerate progress by ensuring that patient experiences remain central to scientific inquiry.

Another major strength of the initiative lies in its collaborative philosophy. Rather than functioning in isolation, the committee is designed to work alongside physicians, institutions, researchers, pharmaceutical developers, and educational organizations. This cooperative approach reflects the growing understanding that meaningful advances in cancer care require multidimensional teamwork between science and lived experience.

The MBCGA also hopes this initiative will inspire more men to become involved in advocacy and research leadership. Many male breast cancer patients remain unaware that advocacy training programs even exist. By opening the door to mentorship and participation, the committee seeks to create a pathway for survivors to transform their personal experiences into meaningful contributions that may improve care for future generations.

In many ways, the Advocate Research Committee symbolizes a broader cultural shift within oncology itself — one that values patient voices not merely as testimonials, but as critical assets in shaping better research, stronger healthcare systems, and more compassionate survivorship care.

The launch of the MBCGA Advocate Research Committee marks a defining moment in the organization’s continued commitment to advancing male breast cancer awareness, research, and patient-centered progress. Through the leadership of Bob Riter, Rod Ritchie, and Michael Singer, the committee stands as a powerful example of how advocacy and science can work hand in hand to drive meaningful change.

As research continues to evolve, the voices of survivors and advocates will remain essential in helping guide priorities, improve trial inclusivity, strengthen educational outreach, and ensure that men facing breast cancer are no longer overlooked in the global cancer conversation.

The future of male breast cancer research will not be built by science alone. It will also be shaped by courageous patients, informed advocates, collaborative partnerships, and communities willing to transform experience into action. The MBCGA Advocate Research Committee is poised to become an important force in that mission — helping bring visibility, credibility, and humanity to the next era of male breast cancer research and survivorship.

For more information or to become involved with the committee, contact: support@mbcga.org